SG Americas Securities, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$390
-48.1%
9,552
-52.7%
0.00%
-66.7%
Q1 2023$752
+8.0%
20,179
+1.1%
0.01%
+12.5%
Q4 2022$696
-99.9%
19,960
+83.4%
0.01%0.0%
Q3 2022$609,000
+67.8%
10,882
+55.0%
0.01%
+100.0%
Q2 2022$363,000
-77.1%
7,019
-67.9%
0.00%
-66.7%
Q1 2022$1,587,000
-57.9%
21,833
-31.5%
0.01%
-40.0%
Q4 2021$3,766,000
+93.2%
31,850
+119.2%
0.02%
+122.2%
Q3 2021$1,949,000
+19.4%
14,527
+44.0%
0.01%
+12.5%
Q2 2021$1,633,000
+80.2%
10,087
-10.6%
0.01%
+60.0%
Q1 2021$906,000
+171.3%
11,286
+83.9%
0.01%
+150.0%
Q4 2020$334,000
-57.6%
6,137
-84.5%
0.00%
-60.0%
Q3 2020$787,000
+8.7%
39,597
+15.0%
0.01%
-16.7%
Q2 2020$724,000
+546.4%
34,427
+317.9%
0.01%
+500.0%
Q4 2018$112,000
-87.6%
8,239
-80.8%
0.00%
-85.7%
Q1 2018$906,000
+258.1%
42,960
+322.5%
0.01%
+250.0%
Q3 2017$253,000
+150.5%
10,169
+61.3%
0.00%
+100.0%
Q2 2017$101,000
-79.0%
6,306
-82.9%
0.00%
-75.0%
Q4 2016$482,000
+5.7%
36,794
+37.2%
0.00%
-20.0%
Q3 2016$456,000
+21.9%
26,815
+53.1%
0.01%
+66.7%
Q2 2016$374,00017,5090.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders